Neoplasms, Ovarian Completed Phase 2 Trials for Olaparib (DB09074)

Also known as: Ovarian neoplasm / Ovarian Neoplasms / Neoplasms,Ovarian / Ovarian neoplasia / Ovarian tumor / Ovarian neoplasm NOS

IndicationStatusPhase
DBCOND0030336 (Neoplasms, Ovarian)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00628251Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian CancerTreatment
NCT00494442Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian CancerTreatment